Litcius/Paper detail

Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial

Edmond M. Kwan, Lavinia Spain, A. Antón, Chun Loo Gan, Linda Garrett, Deborah Chang, Elizabeth Liow, Caitlin Bennett, Tiantian Zheng, Jianjun Yu, Chao Dai, Pan Du, Shidong Jia, Heidi Fettke, Claire Abou-Seif, Gargi Kothari, Mark Shaw, Phillip Parente, Carmel Pezaro, Ben Tran, Shankar Siva, Arun Azad

2021European Urology70 citationsDOI

Topics & Concepts

MedicineProstate cancerClinical endpointInternal medicineProgressive diseaseRadiation therapyUrologySABR volatility modelPhases of clinical researchAvelumabOncologySurgeryClinical trialCancerChemotherapyPembrolizumabImmunotherapyFinancial economicsStochastic volatilityVolatility (finance)EconomicsProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial | Litcius